Advertisement

Central Nervous System Tumors

  • Murat Beyzadeoglu
  • Gokhan Ozyigit
  • Ugur Selek
  • Ugur Selek
Chapter

Abstract

This book, arranged in an MCQ format complemented by oral exam questions, is designed to meet the needs of a wide range of examinees. Essential aspects of radiation physics, radiobiology, and clinical radiation oncology are well covered. Tumors at different sites are addressed in a series of individual chapters, and further chapters are devoted to lymphomas and total body irradiation, pediatric tumors, and rare tumors and benign diseases. The answer keys provide clear explanations for both the correct answers and incorrect statements.

Keywords

Central Nervous System Tumor Spinal Tumor Brain Stem Glioma Posterior Fossa Syndrome Tentorium Cerebelli 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Chang AE, Ganz PA, Hayes DF, Kinsella T, Pass HI, Schiller JH, Stone RM, Strecher V (eds) (2006) Oncology, an evidence-based approach. Springer, New York, pp 487–488Google Scholar
  2. 2.
    Tillmann B (2005) Atlas der Anatomie des Menschen. Springer, Heidelberg, pp 120–122Google Scholar
  3. 3.
    Tillmann B (2005) Atlas der Anatomie des Menschen. Springer, Heidelberg, pp 240–242Google Scholar
  4. 4.
    Louis DN, Ohgaki H, Wiestler OD (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109PubMedCrossRefGoogle Scholar
  5. 5.
    Tonn J-C, Westphal M, Rutka JT, Grossman SA (eds) (2006) Neuro-oncology of CNS tumors. Springer, Berlin/Heidelberg/New York, pp 620–636Google Scholar
  6. 6.
    Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds) (1992) Manual for staging of cancer. American Joint Committee on Cancer, 4th edn. J.B. Lippincott, PhiladelphiaGoogle Scholar
  7. 7.
    Moeller TB, Reif E (2007) Pocket atlas of sectional anatomy, computed tomography and magnetic resonance imaging, vol I, 3rd edn, Head and neck. Thieme, Stuttgart/New York, pp 125–139Google Scholar
  8. 8.
    Brüning R, Küttner A, Flohr T (eds) (2006) Protocols for multislice CT. Springer, Berlin/New York, pp 53–55CrossRefGoogle Scholar
  9. 9.
    National Comprehensive Cancer Network (NCCN) (2007) www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed date: Oct 2007
  10. 10.
    Stieber VW, McMullen KP, DeGuzman A, Shaw EG (2007) Cancers of the central nervous system. In: Khan FM (ed) Treatment planning in radiation oncology, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 415–416Google Scholar
  11. 11.
    Stieber VW, McMullen KP, Munley MT, Shaw EG (2006) Central nervous system tumors. In: Levitt SH, Purdy JA, Perez CA, Vijayakumar S (ed) Technical basis of radiation therapy, 4th rev. edn. Springer, New York/Heidelberg/Berlin, pp 444–446.Google Scholar
  12. 12.
    Gahbauer R, Landberg T, Chavaudra J, Dobbs J et al (2004) Prescribing, recording and reporting electron beam therapy. J ICRU 4(1):100Google Scholar
  13. 13.
    Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352(10):987–996PubMedCrossRefGoogle Scholar
  14. 14.
    Beyzadeoglu M, Ozyigit G, Ebruli C (2010) Basic radiation oncology, 1st edn. Springer, BerlinCrossRefGoogle Scholar
  15. 15.
    Karim AB et al (1996) A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36(3):549–556PubMedCrossRefGoogle Scholar
  16. 16.
    Shaw E et al (2002) Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20(9):2267–2276PubMedCrossRefGoogle Scholar
  17. 17.
    van den Bent MJ et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomized trial. Lancet 366(9490):985–990PubMedCrossRefGoogle Scholar
  18. 18.
    Van den Bent MJ et al (2006) Adjuvant procarbazine, lomustine, and vincristine improve progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24(18):2715–2722PubMedCrossRefGoogle Scholar
  19. 19.
    Laperriere N (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64(3):259–273PubMedCrossRefGoogle Scholar
  20. 20.
    Kristiansen K (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47(4):649–652PubMedCrossRefGoogle Scholar
  21. 21.
    Garden AS (1991) Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 20(2):99–110PubMedCrossRefGoogle Scholar
  22. 22.
    Shapiro WR (1989) Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71(1):1–9PubMedCrossRefGoogle Scholar
  23. 23.
    Nelson DF et al (1988) Combined modality approach to treatment of malignant gliomas–re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 6:279–284Google Scholar
  24. 24.
    Walker MD (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5(10):1725–1731PubMedGoogle Scholar
  25. 25.
    Werner-Wasik M et al (2004) Phase I/II conformal three-dimensional radiation therapy dose escalation study in patients with supratentorial glioblastoma multiforme: report of the Radiation Therapy Oncology Group 98-03 Protocol. Int J Radiat Oncol Biol Phys 60:S163–S164; ASTRO 2004, Abstract 2769CrossRefGoogle Scholar
  26. 26.
    Roa W (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22(9):1583–1588PubMedCrossRefGoogle Scholar
  27. 27.
    Werner-Wasik M et al (1996) Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer 77(8):1535–1543PubMedCrossRefGoogle Scholar
  28. 28.
    Mirimanoff RO et al (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24(16):2563–2569PubMedCrossRefGoogle Scholar
  29. 29.
    Stupp R (2007) Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25:4127–4136Google Scholar
  30. 30.
    Stupp R et al (2009) Effects of radiotherapy with concomittant and adjuvant temozolamide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of EORTC-NCIC trial. Lancet Oncol 10:459–466Google Scholar
  31. 31.
    Roa W (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22(9):1583–1588PubMedCrossRefGoogle Scholar
  32. 32.
    Pignatti F et al (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20(8):2076–2084PubMedCrossRefGoogle Scholar
  33. 33.
    Becker G, Jeremic B, Pitz S et al (2002) Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 54:1422–1429PubMedCrossRefGoogle Scholar
  34. 34.
    Narayan S, Cornblath WT, Sandler HM et al (2003) Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 56:537–543PubMedCrossRefGoogle Scholar
  35. 35.
    Baumert BG, Villà S, Studer G et al (2004) Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Radiother Oncol 72:169–174PubMedCrossRefGoogle Scholar
  36. 36.
    Andrews DW, Scott CB, Sperduto PW et al (2004) WBRT with or without SRS boost for patients with 1–3 brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Murat Beyzadeoglu
    • 1
  • Gokhan Ozyigit
    • 2
  • Ugur Selek
    • 3
  • Ugur Selek
    • 4
  1. 1.Department of RadiationGulhane Military Medical SchoolEtlik, AnkaraTurkey
  2. 2.Department of Radiation Oncology Faculty of MedicineHacettepe UniversitySihhiye, AnkaraTurkey
  3. 3.MD Anderson Cancer CenterUniversity of TexasIstanbulTurkey
  4. 4.MD Anderson Radiation OncologyCenter at American Hospital-Istanbul NisantasiIstanbulTurkey

Personalised recommendations